Capricor Therapeutics to Host Key Opinion Leader Call on the Role of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy (DMD)
Call Scheduled for Thursday, October 24th at 10:30am Eastern TimeLOS ANGELES, Oct. 21, 2019 (GLOBE NEWSWIRE) — Capricor Therapeutics (Nasdaq: […]